Market leadership medi USA sits at the top of compression therapy in the United States with a long-standing 60+ year track record, suggesting credibility and potential for upsell of premium compression products and bundled Orthopedic and Phlebology solutions to existing hospital networks and clinics.

Growth opportunities Parent company medi operates in 26 countries with multiple manufacturing facilities, including a major US operation, indicating potential for expanded distribution partnerships, cross-border product launches, and synchronized supply for larger US healthcare systems and athletic programs.

Tech-enabled selling Existing tech stack including GitHub, MySQL, React and SEO tools points to a digitally savvy operation; leverage e-commerce, product configurators, and CRM-driven outreach to target hospital procurement, orthopedic clinics, and sports medicine practitioners.

Financial fit Revenue range of 50–100 million USD with a strong private ownership structure suggests negotiation flexibility for volume-based contracts, long-term supply agreements, and potential channel partnerships with distributors showing mid-market scale alignment.

Customer targets Product focus on Phlebology, Lymphology, and Orthopedics aligns with hospitals, clinics, and specialty retailers; prioritize opportunities with distributers and care centers serving venous disease, lymphedema, post-surgical rehab, and sports medicine segments.